Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
RBCF, Rev. bras. ciênc. farm. (Impr.) ; 43(4): 571-579, out.-dez. 2007. ilus, tab
Artículo en Inglés | LILACS | ID: lil-479326

RESUMEN

In this study, the effect of ethylcellulose (EC) and 6 types of hydroxypropylmethylcellulose (Methocel® K100M, K100MPRCR, K15MPRCR, K4MPRCR, K4M PR and E4MCR) on release profile of theophylline from matrix tablets was evaluated. Formulations tablets were prepared by either wet granulation or direct compression technique. The tablets were evaluated for physical characteristics and in vitro release of drug was performed as described in USP 30 ed. (Test 3). All formulations with cellulose polymer produced tablets easily and with physicals characteristics in accordance with official limits. Drug dissolution tests showed that formulations with 15 percent of Methocel® K4MPR, 15 percent of Methocel® K4MPRCR and 30 percent of Ethocel® N10STD, obtained by direct compression method, complied with official specifications, in terms of release profile and diffusion was the main mechanism involved in theophylline delivery.


Os efeitos das variáveis das formulações na liberação da teofilina a partir da hidroxipropilmetilcelulose (HPMC) e etilcelulose (EC) em comprimidos matriciais foram estudados. Formulações de comprimidos foram preparadas pelos métodos da granulação úmida ou compressão direta usando diferentes viscosidades de HPMC. Propriedades físico-químicas dos comprimidos e liberação do fármaco foram estudadas conforme dissolução descrita no Teste 3 da Farmacopéia Americana 30ed. Ensaios "in vitro" mostraram que as formulações com 15 por cento de Methocel® K4MPR, 15 por cento de Methocel® K4MPRCR e 30 por cento de Ethocel® N10STD obtidas por compressão direta apresentaram bom perfil de liberação de teofilina e a difusão foi o principal mecanismo envolvido na liberação.


Asunto(s)
Sistemas de Liberación de Medicamentos , Teofilina/administración & dosificación , Comprimidos
2.
RBCF, Rev. bras. ciênc. farm. (Impr.) ; 41(3): 377-384, jul.-set.2005. tab, graf
Artículo en Inglés | LILACS | ID: lil-427933

RESUMEN

Tablets containing theophylline (66.67 porcento) based on a Eudragit® RS 30D and NE 30D matrices containing 10 porcento to 30 porcento of either of the polymer were produced by compression method. The influence of the different proportions of methacrylic esters, the use of lactose and tribasic calcium phosphate as diluents and also the effects of the addition of magnesium stearate as a hydrophobic agent lubricant on the theophylline release, were studied. Physicochemical analyses and drug content was evaluated. In vitro drug release studies were carried out in simulated gastric fluid without pepsin (pH1.2) and simulated intestinal fluid without pancreatin (pH7.5)...


Asunto(s)
Diseño de Fármacos , Técnicas In Vitro , Ácidos Polimetacrílicos , Preparaciones Farmacéuticas/química , Teofilina , Química Farmacéutica , Difusión , Indicadores y Reactivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA